Your Health Plan:
Your Health Plan:
Not SelectedTRUXIMA (rituximab) is a biosimilar prescription drug for treatment of Rheumatoid Arthritis, Granulomatosis with polyangiitis and Microscopic Polyarteritis. TRUXIMA is a cd20-directed cytolytic antibody. It is available in the form of intravenous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $300-3300.